Market Analysis:
Various factors are propelling the
immunoprecipitation market growth. These factors, as per the new MRFR report,
include increasing number of research activities in life science, growing need
for identifying antigens related to autoimmune diseases, and increasing
investments by industries and governments. Additional factors pushing market
report include growing awareness regarding personalized therapeutics, rising
biotechnology research, a growing number of immunoprecipitation assays to
purify and isolate antigens, and repeat purchase of kits.
The global Immunoprecipitation
Market Growth is predicted to touch USD 562 million at a 5.2% CAGR over
the forecast period (2018-2023), states the new Market Research Future (MRFR)
report. Immunoprecipitation (IP), simply put, is a technique to precipitate a
protein antigen out of a solution utilizing an antibody which specifically
binds to that specific protein. The process can be used for isolating and
concentrating a specific protein from a sample having thousands of various
proteins. The IP technique help researchers in identifying the proteins
activation status, determining protein modifications that are
post-translational, measuring a given protein’s molecular weight, and capturing
protein-binding molecules in both the study of protein-nucleic and
protein-protein interactions.
On the flip side, the availability
of alternative protein purification technologies may hamper the
immunoprecipitation market growth over the forecast period.
Key Players:
Leading players profiled in the
immunoprecipitation market report include Geno
Technology Inc., Cell Signaling Technology, Inc., Rockland Immunochemicals
Inc., Takara Bio Inc., BioLegend, Inc., Merck KGaA, Bio-Rad Laboratories, Inc.,
Thermo Fisher Scientific, and Abcam plc, GenScript.
Market Segmentation:
·
The MRFR report provides an all-inclusive segmental analysis of
the immunoprecipitation market report on the basis of product, type, and end
user.
·
Based on type, the immunoprecipitation market is segmented into
RNA immunoprecipitation, chromatin immunoprecipitation, co-immunoprecipitation,
and individual immunoprecipitation.
·
Based on product, the immunoprecipitation market is segmented into
reagent, kit, and others. The reagent segment is again segmented into beads and
antibodies.
·
Based on end user, the immunoprecipitation market is segmented
into contract research organizations, academic and research institutes,
pharmaceutical and biotechnology companies, and others.
Regional Analysis:
By region, the immunoprecipitation
market report covers the latest trends and growth opportunities across the
Americas, Europe, the Asia Pacific, and the Middle East and Africa. Of these,
the Americas will lead the market over the forecast period. Factors aiding
growth in the region include the presence of several market players, increasing
research activities, and a well-developed healthcare sector in the
region.
The immunoprecipitation market in
Europe is predicted to have the second-largest share in the market over the
forecast period. This is chiefly due to the accessibility of funds for
research.
The immunoprecipitation market in
the APAC region is predicted to grow at the fastest pace over the forecast
period. Factors aiding growth in the region include growing awareness regarding
personalized therapeutics, growing biotechnology research in the region, and
growing investment from governments.
The immunoprecipitation market in
the Middle East and Africa is predicted to have a small share in the market
over the forecast period.
No comments:
Post a Comment